Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rocket Doctor AIAIRDF +7.59%27 PS Ratio is 18.48 as of Jul. 19, 2026, which is 47% below its 10-year median of 34.78. GuruFocus rates AIRDF with a GF Score™ of 27/100. The stock has 7 warning signs investors should review. Among 661 Healthcare Providers & Services companies, Rocket Doctor AI ranks worse than 95.16% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Rocket Doctor AI's share price is $0.425.
Rocket Doctor AI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.02. Hence, Rocket Doctor AI's PS Ratio for today is 18.48.
Good Sign:
Rocket Doctor AI Inc stock PS Ratio (=20) is close to 2-year low of 18.06.
The historical rank and industry rank for Rocket Doctor AI's PS Ratio or its related term are showing as below:
AIRDF'
s PS Ratio Range Over the Past 10 Years
Min: 18.06 Med: 34.78 Max: 87.5
Current: 20
During the past 7 years, Rocket Doctor AI's highest PS Ratio was 87.50. The lowest was 18.06. And the median was 34.78.
AIRDF's PS Ratio is ranked worse than 95.16% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 1.5
vs AIRDF: 20.00
Rocket Doctor AI (OTCPK:AIRDF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Rocket Doctor AI PS Ratio Related Terms
Rocket Doctor AI PS Ratio Historical Data
* Premium members only.
The historical data trend for Rocket Doctor AI's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Rocket Doctor AI's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rocket Doctor AI PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rocket Doctor AI's PS Ratio distribution charts can be found below:
* The bar in red indicates where Rocket Doctor AI's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Rocket Doctor AI's Share Price of today is $0.425. Rocket Doctor AI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Rocket Doctor AI (AIRDF) has a PS Ratio of 18.48 as of Jul. 19, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Rocket Doctor AI and its competitors. This is 47% below median its historical median of 34.78. Over the past decade, Rocket Doctor AI's PS Ratio has ranged from 18.06 to 87.50. According to the industry distribution chart, Rocket Doctor AI ranks #629 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 95.2%.
Is Rocket Doctor AI's PS Ratio too high?
Rocket Doctor AI's current PS Ratio of 18.48 is 47% below median its 10-year median of 34.78. Over the past 10 years, this metric has ranged from a low of 18.06 to a high of 87.50. The Healthcare Providers & Services industry median PS Ratio is 1.50. Rocket Doctor AI's value of 18.48 is 1132% above this industry median. Based on the distribution chart, Rocket Doctor AI ranks #629 out of 661 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Rocket Doctor AI has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Rocket Doctor AI ranks #629 out of 661 companies for PS Ratio. This places Rocket Doctor AI in the lower half of its industry. The industry median PS Ratio is 1.50. Rocket Doctor AI's value of 18.48 is 1132% above this benchmark. Historically, Rocket Doctor AI's own PS Ratio has ranged from 18.06 to 87.50 over the past decade. While the company's 10-year median is 34.78 vs. the industry median of 1.50, Rocket Doctor AI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rocket Doctor AI's current PS Ratio of 18.48 is 1132% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Rocket Doctor AI and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rocket Doctor AI's current PS Ratio is 18.48, which is 47% below median its own 10-year median of 34.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current PS Ratio of 18.48. The current PS Ratio is 18.48, which is 47% below median its 10-year median of 34.78 and 1132% above the Healthcare Providers & Services industry median of 1.50. Rocket Doctor AI's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current PS Ratio is 18.48 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
27GF Score
Get the complete analysis for AIRDF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRDF has been successfully added to your 
